As with all diagnostic tests, performance of molecular methods is evaluated by the ability to detect the “target” material at the lowest possible concentration (sensitivity) and the ability to avoid any potential “false positive” reactions (specificity) that may lead to erroneous results.
With this in mind, Arcxis has developed a very unique approach to maximizing the performance of molecular diagnostic tests. Utilizing our proprietary Tentacle Probe™ technology, we are poised to deliver unparalleled accuracy to the clinical laboratory.
The patented Tentacle Probe technology is a dual-powered detection system specifically designed to maximize BOTH sensitivity and specificity. Sensitivity probes effectively grasp all nucleic material present in the sample, acting as a highly effective nucleotide adhesive. Specificity probes act to capture only the specifically targeted nucleic material sought. These two symbiotic steps act in concert to provide unmatched analytical performance.
Copyright 2009 Arcxis Biotechnologies. All rights reserved.
Arcxis Biotechnologies® is a registered trademark of Arcxis Biotechnologies. Tentacle Probes® is a registered trademark of Arcxis Biotechnologies.
Xisyl is a trademark of Arcxis Biotechnologies. ArcPureis a trademark of Arcxis Biotechnologies.
